Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB/c Mouse Model
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB/c Mouse Model
Authors
Keywords
-
Journal
Infection and Drug Resistance
Volume Volume 13, Issue -, Pages 1651-1661
Publisher
Informa UK Limited
Online
2020-06-09
DOI
10.2147/idr.s244081
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intradermal vaccination with a Pseudomonas aeruginosa vaccine adjuvanted with a mutant bacterial ADP-ribosylating enterotoxin protects against acute pneumonia
- (2019) Sarah M. Baker et al. VACCINE
- Mechanistic research holds promise for bacterial vaccines and phage therapies for Pseudomonas aeruginosa
- (2019) Austin Hoggarth et al. Drug Design Development and Therapy
- A Live Salmonella Vaccine Delivering PcrV through the Type III Secretion System Protects against Pseudomonas aeruginosa
- (2019) Julia Aguilera-Herce et al. mSphere
- Rational Design of a Chimeric Derivative of PcrV as a Subunit Vaccine Against Pseudomonas aeruginosa
- (2019) Chuang Wan et al. Frontiers in Immunology
- Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa
- (2018) Ramadan Hassan et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Immune efficacy of DNA vaccines based on oprL and oprF genes of Pseudomonas aeruginosa in chickens
- (2018) Q Gong et al. POULTRY SCIENCE
- Immunization with Pseudomonas aeruginosa outer membrane vesicles stimulates protective immunity in mice
- (2018) Xiaoli Zhang et al. VACCINE
- Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence
- (2017) M. Fata Moradali et al. Frontiers in Cellular and Infection Microbiology
- Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models
- (2017) Feng Yang et al. Scientific Reports
- Immunogenicity of Pseudomonas aeruginosa recombinant b-type fagellin as a vaccine candidate: Protective efficacy in a murine burn wound sepsis model
- (2016) Bahador Behrouz et al. BURNS
- Prevalence of Pseudomonas aeruginosa and antimicrobial-resistant Pseudomonas aeruginosa in patients with pneumonia in mainland China: a systematic review and meta-analysis
- (2016) Chengyi Ding et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Sarkosyl-Induced Helical Structure of an Antimicrobial Peptide GW-Q6 Plays an Essential Role in the Binding of Surface Receptor OprI in Pseudomonas aeruginosa
- (2016) Tien-Sheng Tseng et al. PLoS One
- Key Residues of Outer Membrane Protein OprI Involved in Hexamer Formation and Bacterial Susceptibility to Cationic Antimicrobial Peptides
- (2015) Ting-Wei Chang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania
- (2015) G. Mikucionyte et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii : Mechanisms and epidemiology
- (2015) Anaïs Potron et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A Novel Anti-PcrV Antibody Providing Enhanced Protection against Pseudomonas aeruginosa in Multiple Animal Infection Models
- (2014) Paul Warrener et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Vaccine development and passive immunization for Pseudomonas aeruginosa in critically ill patients: a clinical update
- (2014) Jean-Louis Vincent Future Microbiology
- PcrV antibody protects multi-drug resistant Pseudomonas aeruginosa induced acute lung injury
- (2014) Qin Wang et al. RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
- Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis
- (2014) Dilip Nathwani et al. Antimicrobial Resistance and Infection Control
- Anti-PcrV antibody in cystic fibrosis: A novel approach targetingPseudomonas aeruginosaairway infection
- (2013) Carlos E. Milla et al. PEDIATRIC PULMONOLOGY
- A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of aPseudomonas aeruginosahybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers
- (2013) Kerstin Westritschnig et al. Human Vaccines & Immunotherapeutics
- Pseudomonas aeruginosa: new insights into pathogenesis and host defenses
- (2013) Shaan L. Gellatly et al. Pathogens and Disease
- Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa
- (2012) Bruno François et al. CRITICAL CARE MEDICINE
- PcrV antibody–antibiotic combination improves survival in Pseudomonas aeruginosa-infected mice
- (2011) Y. Song et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia
- (2011) Q. Lu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Multi-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative Bacteria
- (2011) Hiromi Sato et al. Frontiers in Microbiology
- A Fusion Protein Vaccine Containing OprF Epitope 8, OprI, and Type A and B Flagellins Promotes Enhanced Clearance of Nonmucoid Pseudomonas aeruginosa
- (2009) E. T. Weimer et al. INFECTION AND IMMUNITY
- Immunization of young African green monkeys with OprF epitope 8–OprI–type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonasaeruginosa
- (2009) Eric T. Weimer et al. VACCINE
- Good effect of IgY againstPseudomonas aeruginosainfections in cystic fibrosis patients
- (2008) Elin Nilsson et al. PEDIATRIC PULMONOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now